Screening pregnant women at 36 weeks using a validated risk model and offering risk-stratified planned early-term birth ...

Early-life RSV infection and parental allergy interact to substantially increase childhood asthma risk, supported by ...

A systematic review and meta-analysis in eBioMedicine shows that nitrous oxide can rapidly reduce depressive symptoms within ...

A new clinical trial suggests that pairing bispecific antibodies and antibody-drug conjugates with CAR T-cell therapy may ...

This study systematically screened over 1,000 agricultural and industrial chemicals and found that many can inhibit human gut ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate.

SARS‑CoV‑2, the virus that causes COVID-19, continues to mutate, with some newer strains becoming less responsive to current antiviral treatments like Paxlovid.

Most patients with a rare and aggressive form of large B-cell lymphoma can safely receive a less toxic treatment than the ...

In adults with stage IIIb–IV chronic kidney disease, the constipation drug lubiprostone did not reduce gut-derived uremic ...

A study funded in part by the National Institutes of Health (NIH) has revealed important insights into the genetics of deposits in the eye, known as reticular pseudodrusen (RPD), that are linked to ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible for drug-resistant epilepsy.